Skip to main content
. Author manuscript; available in PMC: 2007 Mar 13.
Published in final edited form as: Eur J Epidemiol. 2006 Sep 20;21(8):619–625. doi: 10.1007/s10654-006-9041-x

Table 2.

Number of received sample sets and sample types stored at the Biobank

Stored sample types, ready for retrieval in the MoBa study as of July 2006
Number of sets sample Whole blood Plasma microtitre plates Plasma Matrix Heparin Plasma Matrix EDTA Whole blood for metals (FE3) Urine Matrix without chlorhexidine Urine Matrix with chlorhexidine DNAf
M11a 17,131 16,561 16,883 13,542
M12b 51,254 49,630 50,308 10,116 40,050 48,460 9,488 40,020 33,475
M2c 53,889 52,878 53,437 39,444
Cd 57,573 34,737 56,679 39,581
Fe 47,663 47,108 47,296 33,432
Total 227,510 200,914 224,603 10,116 40,050 48,460 9,488 40,020 159,474
a

M11 = Mother 1 sample, blood sample set from mothers at 17th week of pregnancy, two 7-ml EDTA tubes drawn.

b

M12 = Mother 1 sample, blood sample set from mothers at 17th week of pregnancy, including tubes for environmental factors.

c

M2 = Mother 2 sample, blood sample set from mothers at delivery.

d

F = Father, blood sample set from fathers at 17th week of pregnancy.

e

C = Cord, blood sample from the babies umbilical cord or a capillary sample from the PKU screening. 1.8% of samples from babies are obtained in this way.

f

The deviation in number of registered samples and DNA samples is that not all DNA samples have been adjusted for concentration, which is needed for DNA aliquoting, and to give location on plates for storage.